Product correctly added to cart.

discount label
S18-000003
View 3D

Biosynth logo

S18-000003

CAS: 2068119-11-7

Ref. 3D-THD11911

1mgTo inquire
2mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
Estimated delivery in United States, on Tuesday 2 Jul 2024

Product Information

Name:
S18-000003
Description:

Pro-inflammatory cytokines are a class of proteins that are integral to the immune response. The pro-inflammatory cytokine IL-17 is a crucial player in autoimmune disorders, as it promotes inflammation and protects against invading bacteria and fungi. IL-17 also has an important role in the development of cardiac disease, as it stimulates inflammation in heart tissue and can lead to cardiac damage. It is believed that the inhibition of IL-17 could provide new therapeutic strategies for autoimmune diseases and inflammatory diseases. S18-000003 is a synthetic drug that targets IL-17 production by binding to the retinoic acid receptor (RAR) beta, which is the target for retinoic acid synthesis. This drug has been shown to reduce the production of pro-inflammatory cytokines such as IL-17, providing a potential therapeutic strategy for autoimmune disorders and inflammatory diseases.

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
518.5 g/mol
Formula:
C26H25F3N2O4S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-THD11911 S18-000003

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".